Results 131 to 140 of about 81,803 (228)

Correction: Novel lncRNA-IUR suppresses Bcr-Abl-induced tumorigenesis through regulation of STAT5-CD71 pathway. [PDF]

Mol Cancer
Wang X, Yang J, Guo G, Feng R, Chen K, Liao Y, Zhang L, Sun L, Huang S, Chen JL.   +9 more
europepmc   +1 more source

Treatment response and survival outcomes with BCR-ABL tyrosine kinase inhibitors in chronic myeloid leukemia: a retrospective study. [PDF]

Front Med (Lausanne)
Liu Y, Zhang L, Zeng L.
europepmc   +1 more source

A case report of BCR-ABL(+) acute myeloid leukemia and literature review. [PDF]

Front Oncol
Li J, Zheng W, Dong X, Wang J, Liu K.
europepmc   +1 more source

Repurposing primaquine diphosphate for imatinib-resistant chronic myeloid leukemia via targeting BCR-ABL and Wnt/β-catenin pathway. [PDF]

iScience
Yin C, Liu W, Ma C, Zhang Z, Fang Z, Cao J, Wu G, Gu H, He L.   +8 more
europepmc   +1 more source

Pulmonary Arterial Hypertension Risk With BCR-ABL Tyrosine Kinase Inhibitors: Refining Risk With Nationwide Data. [PDF]

Circulation
Garry JD, Brittain EL.
europepmc   +1 more source

Immunogenicity of BCR-ABL-regulated tumorantigens

, 2009
Im Hinblick auf die Entwicklung alternativer, immuntherapeutischer Ansätze zur Behandlung der Ph-positiven chronisch myeloischen Leukämie (CML) wurde in der vorliegenden Arbeit die Immunogenität des BCR-ABL-Fusionsproteins selbst, und der durch die BCR ...
Scheich, Florian
core  

Development of a Highly Sensitive SPR Biosensor for BCR-ABL Gene Sequence Detection Using a Novel Gold Nanoparticle-Enhanced Sandwich Assay Format. [PDF]

Micromachines (Basel)
Sobolevskyi MS, Lopatynskyi AM, Samoylov AV, Dorozinsky GV, Lyapin OM, Khrystosenko RV, Chegel VI, Pyeshkova VM, Errachid A, Dzyadevych SV, Soldatkin OO.   +10 more
europepmc   +1 more source

RETRACTED: Li et al. Blockade of Y177 and Nuclear Translocation of Bcr-Abl Inhibits Proliferation and Promotes Apoptosis in Chronic Myeloid Leukemia Cells. <i>Int. J. Mol. Sci.</i> 2017, <i>18</i>, 537. [PDF]

Int J Mol Sci
Li Q, Huang Z, Gao M, Cao W, Xiao Q, Luo H, Feng W.   +6 more
europepmc   +1 more source

Rational Design, Synthesis, and Molecular Docking of Novel Terpene Analogues of Imatinib, and Their Inhibition on Downstream BCR-ABL Signaling. [PDF]

Pharmaceuticals (Basel)
Mihaylova R, Dailova-Barzeva A, Philipova I, Momekov G, Doytchinova I, Atanasova M, Stavrakov G.   +6 more
europepmc   +1 more source

Second- and Third-Generation BCR-ABL Tyrosine Kinase Inhibitors and the Risk of Pulmonary Arterial Hypertension: A Prevalent New-User Design. [PDF]

Circulation
Jambon-Barbara C, Suissa S, Dell'Aniello S, Hlavaty A, Cracowski JL, Chaumais MC, Humbert M, Montani D, Khouri C.   +8 more
europepmc   +1 more source